Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
Date:2/27/2013

urope and other territories;
  • the size of the market, future growth potential and market share for Cinryze, Buccolam and Plenadren in Europe;
  • the availability of sufficient third party payer reimbursement for each of our products in the United States and Europe;
  • fluctuations in wholesaler order patterns and inventory levels;
  • competition from the approval of products which are currently marketed for other indications by other companies or new pharmaceuticals and technological advances to treat the conditions addressed by Cinryze, Vancocin, Buccolam and Plenadren;
  • changes in prescribing or procedural practices of physicians, including off-label prescribing of products competitive with Vancocin, Cinryze, Buccolam and Plenadren;
  • manufacturing, supply or distribution interruptions, including but not limited to our ability to acquire adequate supplies of Cinryze and our other products in order to meet demand for each product;
  • our ability to receive regulatory approval for the use of Cinryze for additional indications and routes of administration and in additional territories in the timeframes we anticipate or at all;
  • the impact of healthcare reform legislation in the United States;
  • actions by the FDA and EMA or other government regulatory agencies;
  • the timing and results of anticipated events in our clinical development programs including studies with Cinryze subcutaneous formulation, Cinryze for antibody mediated rejection, maribavir for treatment of CMV infections in transplant recipients, as well as VP20621 for recurrence of C. difficile; and,
  • the timing and nature of potential business development activities related to our efforts to expand our current portfolio through in-licensing or other means of acquiring products in clinical development or marketed products.
  • There can be no assurance that we will conduct additional studies or that we will
    '/>"/>

    SOURCE ViroPharma Incorporated
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
    2. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
    3. ViroPharma To Participate In The JMP Securities Healthcare Conference
    4. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
    5. ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
    6. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
    7. ViroPharma to Present at the Stifel Nicolaus 2012 Healthcare Conference
    8. ViroPharma To Host Analyst And Investor Seminar On September 21, 2012
    9. ViroPharma Incorporated Reports Third Quarter 2012 Financial Results
    10. ViroPharma Launches Novel Campaign to Illustrate the Emotional Burden of Hereditary Angioedema
    11. ViroPharma To Participate In Two Upcoming Healthcare Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... BRUSSEL , 31 juli 2014 De ... van een rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf ... Brussel gevestigde PCRU is één van twee ... met als ideaal levens te verbeteren door de ontdekking ... is de PCRU op zoek naar mannen en vrouwen ...
    (Date:7/30/2014)... , July 30, 2014  There is ... chain organization,s success. The 10th Annual Institute for ... Awards for Excellence in Supply Management is open ... further the understanding and importance of supply management ... leadership and best supply management practices.  Entries are ...
    (Date:7/30/2014)... -- Advanced Photonix ® (NYSE MKT: API) will announce ... on Monday, August 11, 2014. A press release announcing the ... market and the Company will host a live audio web ... the same day. Participating in the call will ... Risser (COO and Director), and Jeff Anderson ...
    Breaking Medicine Technology:Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2
    ... Approximately one-half of all infants are infected with the respiratory ... all children have been infected at least once by the time ... have discovered what makes RSV such a severe and persistent illness. ... his team have discovered that RSV prompts the release of a ...
    ... Australia, Sept. 3 Cytopia Limited,s (ASX: CYT) Investigational New ... Drug Administration (FDA) review. CYT387 is a small-molecule oral JAK1/JAK2 ... IND application is now active and Cytopia is able to ... , , CYT387 will be the second ...
    Cached Medicine Technology:Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive 2Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive 3Cytopia's CYT387 Receives FDA Clearance to Start US Clinical Trials 2
    (Date:7/30/2014)... (PRWEB) July 30, 2014 Nationally recognized ... CNE, ANEF, who since September 2013 has served as ... became the new dean of the College of Nursing ... move marries her leadership of the NLN, as the ... the top-ranked academic nursing and research institutions in the ...
    (Date:7/30/2014)... Within weeks freshman will begin to pour onto college ... will be a time of growth and the start to something ... may not be as easy as it looks. Some sources ... major at least once and many will switch two or three ... are exacerbated when switching in the later years of college. According ...
    (Date:7/30/2014)... Throughout the month of August, Restore ... cancer screenings. Using a new technological tool called The ... disease in its early stages. , Oral cancer can ... throat and other areas in and around the mouth. ... Ends Results (SEER) program, 30 percent of oral cancers ...
    (Date:7/30/2014)... Cucamonga, CA (PRWEB) July 30, 2014 Serial ... learning how to make millions. However, like most people, in ... Determined to find a better way, Paul carefully studied ... wealth and those who do not. Based on the knowledge ... to not only improve his life and health, but also ...
    (Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 ... to develop dementia, but researchers have been unable to explain ... Specifically, they haven,t been able to figure out the direction ... on dementia, or does dementia cause people to become depressed? ... journal Neurology sheds more light on the mystery. ...
    Breaking Medicine News(10 mins):Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 2Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 3Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3
    ... for UGIB should be performed within 24 hour from the admission. ... it should be performed either very early i.e. within 2 ... 6, 12 or 24 hour. Therefore, optimal timing for urgent endoscopy ... article to be published on August 28, 2008 in the ...
    ... 9 Heritage Victor Valley,Medical Group announced today ... Club. The Victorville Senior Citizen Club sponsors,educational, social ... The computers will be used for work stations ... programs at the Club., "The Victorville Senior ...
    ... Brinks Hofer Gilson & Lione, one of,the largest intellectual ... that Jacob Cheung-Ka Ong has joined the firm,s Salt ... Cheung-Ka Ong received a B.S. in neuroscience from Brigham ... University of,California-San Diego, La Jolla. He received his J.D. ...
    ... Bias Correction of Familial Risk Estimates Increases Estimated Melanoma ... , The relative risk of familial melanoma increases substantially ... a large cohort study. The relative risk of familial ... substantially with the correction. , Researchers have used the ...
    ... (Sept. 9, 2008) Both higher fish consumption and ... development in infants, according to a study of mothers ... breastfeeding were independently beneficial. , "These results, together with ... and the United Kingdom, provide additional evidence that moderate ...
    ... Firm Will Grow Through Leadership Development and Technological Efficiency ... ... Ga. (Vocus) September 9, 2008 -- http://www.jacksonhealthcare.com/companies.aspx ... of Alpharetta, Ga.-based http://www.locumtenens.com/new_leader08 [LocumTenens.com]. Working ...
    Cached Medicine News:Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 2Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 3Health News:R. Shane Jackson Named President of LocumTenens.com 2Health News:R. Shane Jackson Named President of LocumTenens.com 3
    ... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
    ... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
    ... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
    ... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
    Medicine Products: